There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/28
Jump to navigation
Jump to search
Pages in category "C07K16/28"
The following 28 pages are in this category, out of 28 total.
1
- 17767856. ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS simplified abstract (Arizona Board of Regents on Behalf of Arizona State University)
- 17769171. COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES simplified abstract (The Regents of the University of California)
- 18193062. CANCER TREATMENT COMBINATIONS simplified abstract (The Regents of the University of California)
- 18234229. METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18267257. T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY simplified abstract (SANOFI)
- 18274979. IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS simplified abstract (The Regents of the University of California)
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18480038. ANTIBODY FUSION PROTEIN AND RELATED COMPOSITIONS FOR TARGETING CANCER simplified abstract (Arizona Board of Regents on Behalf of Arizona State University)
- 18517327. BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE simplified abstract (Genentech, Inc.)
- 18546081. MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN ROR1 simplified abstract (The Regents of the University of California)
2
- 20240010707. De-immunized Factor VIII Molecule and Pharmaceutical Compositions Comprising the Same simplified abstract (Biotest AG)
- 20240010980. NATURAL KILLER CELLS WITH ENHANCED ACTIVITY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 20240025963. DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES simplified abstract (2seventy bio, Inc.)
- 20240052039. PROTEIN, POLYNUCLEOTIDE, VECTOR, HOST CELL, COMPOSITION, METHOD FOR TREATING AN ILLNESS, IN-VITRO METHOD FOR PREDICTING MULTIPLE SCLEROSIS, AND USE OF A PROTEIN OR COMPOSITION simplified abstract (Fundação Oswaldo Cruz)
- 20240052392. CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION simplified abstract (GENENTECH, INC.)
B
- Blockchain patent applications on 22nd Mar 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 29th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 25th, 2024
- Blockchain patent applications on March 21st, 2024
- Blockchain patent applications on March 7th, 2024